Protective efficacy of a human endogenous retrovirus envelope-coated, nonreplicable, baculovirus-based hemagglutin vaccine against pandemic influenza H1N1 2009.

Protective efficacy of a human endogenous retrovirus envelope-coated, nonreplicable, baculovirus-based hemagglutin vaccine against pandemic influenza H1N1 2009.

Despite the advantages of DNA vaccines, overcoming their lower efficacy relative to that of conventional vaccines remains a challenge. Here, we constructed a human endogenous retrovirus (HERV) envelope-coated, nonreplicable, baculovirus-based HA vaccine against swine influenza A/California/04/2009(H...

Full description

Bibliographic Details
Main Authors: Jae-Yoo Choi, Yong-Dae Gwon, Jeong-Ki Kim, Yeon-Dong Cho, Yoon-Ki Heo, Han-Sam Cho, Tae-Jin Choi, Ha-Ryoung Poo, Yu-Kyoung Oh, Young Bong Kim
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2013-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3832454?pdf=render

Internet

http://europepmc.org/articles/PMC3832454?pdf=render

Similar Items